Nov. 20, 2014, 7:11 AM
- The Wall Street Journal reports that Fresenius (NYSE:FMS) and the Permira investment fund have made an offer for Danone's (OTCQX:DANOY) (OTCPK:GPDNF) medical nutrition business. The size of the bid is unknown, but according to analysts the business is worth between €3.5B - 4.5B ($4.38B - 5.64B).
- The private equity fund CVC is reportedly mulling an offer as well.
- The deadline for bids is next week.
Nov. 13, 2014, 7:53 AM
- Fresenius Medical Care (NYSE:FMS) acquires Cogent Healthcare, a U.S. provider of specialist physicians to hospitals, for an undisclosed sum. The takeover was executed by Sound Inpatient Physicians, in which Fresenius owns a majority stake. Cogent is forecasted to generate $250M in top line revenue in 2015.
- The acquisition is consistent with FMS' plan to build a $5B care-coordination business by 2020 that will offer a wide range of care for the chronically ill. The company expects to double its group sales to $28B by then.
- Medical insurers are moving to a system of lump sum payments for caring for dialysis patients rather than reimbursing for individual drugs and services. Insurers hope this system, called care coordination or disease management, will encourage healthcare providers to focus more intently on the prevention of medical complications and increase patients' compliance with treatment regimens.
- FMS expects the Cogent deal to be accretive to group earnings with 18 -24 months. The transaction should close by year end.
Oct. 22, 2014, 1:29 PM
- Fresenius Medical Care (FMS -0.2%) acquires National Cardiovascular Partners (NCP) for an undisclosed sum. The company expects the acquisition to add more than $200M to the top line in 2015 and be accretive to earnings in the first year after closing.
- NCP is a leading operator of endovascular, vascular and cardiovascular services in the outpatient setting. It partners with over 200 doctors in 21 outpatient vascular centers in six states.
Jun. 27, 2014, 2:14 PM
- Fresenius Medical Care (FMS +1.5%) enters into an agreement to invest ~$600M in Sound Inpatient Physicians, a hospital inpatient care delivery organization. Its stake will make it the majority shareholder in the recapitalization of Sound. Other major shareholders are TowerBrook Capital Partners and the group's senior management.
- Sound Physicians encompasses more than 1,000 doctors providing care in over 100 hospitals and post-acute care centers across the U.S.
- Fresenius CEO Ron Kuerbitz says, "This investment in Sound's inpatient expertise is a significant step forward in our care coordination strategy and augments our network of 2,150 dialysis clinics, 53 vascular care centers, renal pharmacy and full service and specialty laboratories to help us better address the full spectrum of our patients' health care needs."
Sep. 13, 2013, 1:58 AM
- Fresenius Medical Care's (FMS) sister company Fresenius Helios has agreed to acquire 43 hospitals in Germany for €3.07B ($4.1B) from Rhoen-Klinikum in a deal that will create the largest operator of private hospitals in Europe. Fresenius will pay for the deal with debt.
- The companies also intend to work together in a network that will include Rhoen's other hospitals.
- The purchase will add €2B a year in revenue and $250M in EBITDA.
- The transaction comes after Fresenius last year failed to buy all of Rhoen-Klinikum for €3.1B. (PR)
Sep. 3, 2012, 4:22 AMFresenius (FMS) drops a €3.1B bid for private-clinic operator Rhoen-Klinikum. Fresenius had planned to make a second offer at an unchanged price of €22.50/share, but the German health-care company's supervisory board wasn't overly keen on the deal, while a rival hospital operator filed an application to raise its stake in Rhoen-Klinikum to 10% in order to torpedo Fresenius. (PR) | Comment!
Aug. 2, 2011, 3:31 AMFresenius Medical Care (FMS), the world's largest dialysis company, agrees to buy Liberty Dialysis Holdings for $1.7B including assumed debt, and American Access Care Holdings for $385M. The deals come as a new Medicare payment scheme pressures dialysis clinics to increase efficiency. (PR) | Comment!
FMS vs. ETF Alternatives
Other News & PR